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Abbreviations 
ORF     Open Reading Frame 
SD  Shine-Dalgarno 
GFP  Green Fluorescent Protein 
E. coli  Escherichia coli 
DDM  n-Dodecyl β-D-Maltopyranoside 
IMAC  Immobilized Metal Affinity Chromatography 
FSEC  Fluorescent Size Exclusion Chromatography    
AC
CE
PT
ED
 M
AN
US
CR
IPT
ACCEPTED MANUSCRIPT
3 
 
Abstract 
Functional overexpression of membrane proteins is essential for their structural and 
functional characterization. However, functional overexpression is often difficult to 
achieve, and frequently either no expression or expression as misfolded aggregates is 
observed. We present an approach for improving the functional overexpression of 
membrane proteins in E. coli using transcriptional fusions. The method involves the use 
of a small additional RNA sequence upstream to the RNA sequence of the target 
membrane protein and results in the production of a bicistronic mRNA. In contrast to the 
common approach of translational fusions to enhance protein expression, transcriptional 
fusions do not require protease treatment and subsequent removal of the fusion protein. 
Using this strategy we observed improvements in the quantity and/or the quality of the 
produced material for several membrane proteins to levels compatible with structural 
studies. Our analysis revealed that translation of the upstream RNA sequence was not 
essential for increased expression. Rather, the sequence itself had a large impact on 
protein yields, suggesting that alternative folding of the transcript was responsible for the 
observed effect.  
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Introduction 
The heterologous overexpression of well-folded protein remains one of the main 
bottlenecks for structural biology of membrane proteins. Despite our expanding 
knowledge on the factors involved, establishing and optimizing membrane protein 
overexpression is currently still a largely empirical process. General strategies used for 
E. coli involve the screening of several parameters such as expression hosts, promoters, 
growth conditions, coding sequences, tags and fusion proteins [1].  
The use of fusion proteins for expression in E. coli was extensively explored for soluble 
proteins and later successfully used for membrane proteins as well. In general, fusion 
proteins represent independent folding domains that do not interact with their fused 
protein target. Fusion proteins are mostly hydrophilic and vary in size from 10 to 60 kDa 
[2–4]. They can be fused either to the N- or C-terminus of the target protein. The latter is 
often employed to monitor the folding state of the target proteins using a fusion partner 
that  allows   facile   ‘read-out’,   such  as GFP [5, 6] or antibiotic resistance markers [7, 8]. 
Fusions to the N-terminus of the target protein are generally used for their favourable 
properties in enhancing expression levels [3] and decreasing proteolysis [4]. Both types 
of fusions can be used to detect and even purify the target protein. Commonly used 
fusion proteins are MBP, the maltoside binding protein from E. coli [9,10], Trx (E. coli 
thioredoxin [11]), SUMO, (small ubiquitin-like modifier from S. cerevisiae, [12]), and 
Mistic (membrane integrating sequence for translation of inner membrane protein 
constructs from B. subtilis) [13]. In addition, novel fusion partners are constantly 
introduced, such as YnaI and YbeL, two small hydrophilic proteins from E. coli that have 
been recently reported to enhance the production of functional membrane proteins in E. 
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coli [14]. Although N-terminal fusions can be important for targeting the nascent 
membrane protein to the membrane for insertion or for decreasing its susceptibility to 
proteolysis, the often-observed ability of N-terminal sequences to enhance expression 
levels is often attributed to their high initiation rate of translation due to favourable mRNA 
secondary structure [15, 16]. 
Nevertheless, the application of fusion proteins should be done with some caution. The 
fusion protein can affect the folding state of the target protein, e.g., if too short linkers 
are used to connect both proteins [10]. Furthermore, the activity of the target protein can 
be compromised by the fusion [17–19], and the presence of a flexible fusion protein can 
interfere with crystallization [20]. A solution to the latter issues is to perform proteolytic 
cleavage and removal of the fusion protein, but efficient cleavage cannot always be 
achieved [21]. 
A potential alternative to translational fusions could be transcriptional fusions. Such 
fusions are common in prokaryotes and result in transcripts containing multiple open 
reading frames (ORFs) that are translated separately. The genomic sequence of E. coli 
shows that more than 25% of all operons are polycistronic and approximately 9% of the 
ORFs have a start codon overlapping with the stop codon of the preceding ORF [22]. 
This system allows simultaneous and stoichiometry-regulated expression of proteins that 
are functionally related. Examples of such bacterial operons are found in multiprotein 
complexes as the ribosome [23], the ATP synthase [24], the anthranilate and tryptophan 
synthases [25], and photosynthetic complexes [26].  
Translation of ORFs that are preceded by another ORF can result from either re-
initiation or de novo initiation [27]. In re-initiation, the ribosome completing translation of 
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the upstream ORF remains bound to the transcript. Translation of the downstream ORF 
is initiated when a start codon nearby or overlapping with the stop codon of the 
preceding ORF is encountered. The presence of a Shine-Dalgarno (SD) sequence 
upstream to the start codon enhances the re-initiation efficiency, but is not strictly 
necessary [27–29]. Translation of the upstream ORF is suggested to be necessary as 
the helicase activity of the ribosome opens up secondary structures and makes 
elements as the SD sequence or the start codon accessible [27–30]. For de novo 
initiation, a novel 30S ribosomal subunit binds directly to the SD preceding a secondary 
ORF on the transcript. This mode of initiation requires an exposed SD not involved in 
mRNA secondary structure [27]. 
As the beneficial effects of translational fusions on protein expression are mostly 
attributed to more favourable secondary structures in the transcript, we investigated 
whether similar beneficial effects could also be achieved using transcriptional fusions, 
which would avoid enzymatic cleavage to liberate the target protein. Here we compare 
the effect on membrane protein overexpression for translational and transcriptional 
fusions of genes coding for the fusion proteins Mistic, SUMO and YbeL, and 
demonstrate an application for transcriptional fusions. 
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Results 
Overexpression of membrane proteins using transcriptional fusions 
To compare translational and transcriptional fusions four evolutionary unrelated 
polytopic membrane proteins (MP) from E. coli were selected that could be functionally 
expressed without N-terminal fusions and which possessed a cytoplasmic C-terminus 
[31]. The latter allowed the use of C-terminal GFP fusions to rapidly assess the ratio 
between well-folded and misfolded protein by gel electrophoresis [6]. Though the 
fluorescence of C-terminal GFP fusion proteins is an indirect indication for correct 
folding, a very high correlation between GFP fluorescence and functional and stably 
folded membrane proteins is generally observed [5, 6, 32]. ORFs coding for the glycine 
betaine/proline ABC transporter permease ProW [5, 33], the mechanosensitive channel 
of large conductance MscL [33, 34], the lactose permease LacY [6, 35] and the 
glutamate transporter GltP [6] were placed under the control of the arabinose promoter 
[36] and fused to the sequence coding for a C-terminal GFP in a diverse set of universal 
high-throughput cloning vectors (Fig.1) [37]. These vectors allowed direct expression of 
the target ORF-GFP alone, with translational fusions to Mistic, SUMO or YbeL, or with 
transcriptional fusions to mstX, sumo, or ybeL (Fig. 1). Translation using the first two 
vector sets was initiated using the SD of the vector. Vectors for transcriptional fusions 
had overlapping stop and start codons, and were either preceded by a SD (for mstX and 
ybeL) or a sequence devoid of SD (for sumo). The mstX gene is naturally part of a two-
gene operon [38] and contains a SD sequence that is necessary for efficient translation 
of the downstream ORF yugO [39]. Instead, ybeL is not part of an operon, but 
possesses a GA-rich sequence in the vicinity of its stop codon that is predicted to 
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function as a SD. Predicted translation efficiencies (RBS-Designer software [40]) were in 
the same range for all vectors except for the plasmid for transcriptional fusion to sumo 
that did not contain an additional SD preceding the target ORF (Fig. 1). The importance 
of the SD present on mstX and ybeL for achieving translation of the downstream ORF 
was further investigated by creating vectors devoid of the SD sequences, and as well by 
introducing a SD sequence into sumo (Fig. 1, Suppl. 1). 
Improved membrane protein folding quality using transcriptional fusions 
All target proteins in the context of the different vectors were expressed in E. coli 
following the same growth and induction protocol. Expression levels were determined by 
the combination of in gel GFP fluorescence and immunoblotting (Fig. 2). In addition, the 
GFP fluorescence in whole cells was determined (Suppl. Fig. 1A). All four constructs 
yielded well-folded membrane proteins without a translation or transcriptional fusion, as 
judged from the observed GFP fluorescence bands corresponding to the expected sizes 
of the respective MP-GFP fusions (Fig. 2; left panels). However, large fractions of the 
produced proteins were misfolded, as indicated by the strong non-fluorescent band 
migrating 10-15 kDa higher than the fluorescent band (Fig.2; right panels). The presence 
of N-terminal translational fusion partners overall decreased the functional expression 
levels for ProW, LacY and GltP, while for MscL increased levels were observed.   
Transcriptional fusion with sumo did not lead to detectable expression levels for all 
tested proteins, in contrast to fusions with mstX and ybeL. The insertion of a SD into the 
sumo DNA sequence was able to alleviate the failing expression, though expression 
levels remained very low (Suppl. Fig. 1A). Transcriptional fusions to mstX or ybeL led to 
a modest increase in functionally expressed protein for ProW and LacY as compared to 
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expression without fusion (Suppl. Table 4A). Remarkably, the increase in the amount of 
well-folded material was not paralleled by a similar increase in the amount of misfolded 
protein. This is most clearly observed for the ybeL transcriptional fusions, which led to a 
significant reduction in the fraction of misfolded membrane protein. 
Translational and transcriptional fusions do not alter expression profiles 
It is well established that very high membrane protein expression rates can exceed the 
capacity of the cell to properly target, insert and/or fold membrane proteins [6, 41]. This 
leads to an increased fraction of misfolded membrane proteins at high expression rates. 
To exclude that the decreased levels of misfolded protein observed for transcriptional 
fusions to mstX and ybeL resulted from a decreased transcript concentration and 
consequently lower expression rates, we tuned the promoter strength by varying the 
arabinose concentration during induction [6, 36]. To identify the optimal inducer 
concentration for the four membrane proteins under study, the expression levels of all 
constructs were determined by measuring GFP fluorescence in whole cells at six 
different arabinose concentrations (Suppl. Fig. 2). Curves indicate that the relative 
expressions levels for all constructs at different arabinose concentrations are very 
similar, with an optimum around 2x10-2 % (w/v) arabinose. Therefore, the improved 
ratios between well-folded and misfolded membrane proteins in the fusion constructs 
cannot be attributed to inappropriately chosen inducer concentrations, but rather 
represent an intrinsic feature of the constructs.  
Additional assessment of the protein folding quality 
Though GFP fluorescence is a strong indicator of correct folding of the preceding 
membrane protein, we additionally verified the quality of the GFP-fusion proteins by 
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determining their n-dodecyl β-D-maltoside (DDM) extraction efficiency (Suppl. Table 2). 
We have chosen DDM as this is a mild detergent that preferentially solubilizes correctly 
folded MPs [6]. Protein produced using either direct expression or transcriptional fusions 
could be extracted efficiently (between 75-90%). We noticed that poor extractability was 
achieved when the four MPs were expressed as translational fusions with Mistic 
(between 25-50%), while translational fusions with SUMO or YbeL could be extracted 
with intermediate efficiencies (between 50 and 80%). These reduced solubilization 
efficiencies suggest that the stability of the proteins produced by translational fusions is 
decreased. 
All samples solubilized by DDM were subsequently analyzed by fluorescence size-
exclusion chromatography (FSEC) as an additional means to verify their folding state 
(Suppl. Fig. 3). All proteins that had intermediate to high solubilization efficiencies were 
monodisperse (ProW and LacY) or oligodisperse (GltP and MscL). Except for MscL, all 
proteins showed similar migration profiles as the proteins produced using direct 
expression. For MscL, direct expression resulted in little detergent-solubilized 
fluorescent protein that displayed non-uniform migration during FSEC. Increased 
quantities of more uniform MscL could be obtained only using translational or 
transcriptional fusions. 
Application of transcriptional fusions to difficult-to-express membrane proteins 
The modest increase in well-folded material using transcriptional fusions with mstX and 
ybeL for membrane proteins that had previously been demonstrated to express well [31] 
made us ask whether this methodology could be applied to membrane proteins that 
either showed overall low expression levels or large proportions of misfolded material. 
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We selected E. coli AraH and NarK, E. faecalis EF583/584, and the human Y4 GPCR 
based on their reported low expression levels and cytoplasmic carboxy-terminus. AraH 
is a component of the E. coli L-arabinose ABC transporter permease (AraFG2H) and 
NarK is a nitrite/nitrate antiporter. Both were shown to express poorly [42], though 
overexpression of the latter proved possible later upon small modifications in the 
expression conditions [43]. The poorly expressing ABC transporter EF583/584, encoded 
by two overlapping genes (EF0583/0584), was selected based on a high-throughput 
expression screening which lead to the crystallization of the heterodimeric ABC 
transporter TM287/288 [44]. As an example of a difficult-to-express eukaryotic 
membrane protein, we have used the human Y4 receptor, a G-protein coupled receptor 
(GPCR) that could only be produced with modest expression levels in E. coli using N-
terminal fusions [45].  
Production levels of these four targets, expressed directly or via transcriptional fusion, 
were determined by the combination of in gel GFP fluorescence and immunoblotting 
(Fig. 3) and whole cell GFP fluorescence (Suppl. Fig. 1B). The induction time for 
expression of AraH, NarK, EF583/584 and Y4 GPCR was extended by approximately 12 
h compared to the well-expressed proteins ProW, MscL, LacY and GltP in order to 
obtain significant GFP signals.  
In contrast to previous observations [42], we could achieve expression of AraH when 
directly expressed (Fig. 3). Furthermore, the expression conditions applied here also 
allowed direct expression of NarK. These differences are likely to results from the use of 
a milder promoter system. Nevertheless, expression levels of all four target proteins 
were low or resulted in large amounts of misfolded material. 
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The use of transcriptional fusions to mstX or ybeL improved the expression levels for all 
targets, though expression levels of the Y4 GPCR remained very poor (Fig. 3, Suppl. 
Table 4B). Noteworthy, the low but significant fluorescence observed for the Y4 GPCR 
in whole cells (Suppl. Fig. 1B) did not translate to a similar in gel GFP signal, neither for 
full-length Y4-GFP nor for breakdown products or higher molecular weight aggregates 
(Fig. 3). The cause for this discrepancy is presently unclear. As the in gel GFP 
fluorescence allows specific assignment of a signal to the full-length GFP fusion protein, 
in contrast to measurements in whole cells that can only detect bulk fluorescence, we 
interpret the relatively high GFP fluorescence in whole cells as an overestimation of the 
Y4 GPCR levels.  
Overall, transcriptional fusions to ybeL proved best: not only were increased levels of the 
fluorescent species observed, but these were accompanied by decreased levels of 
misfolded protein as well, as observed previously. Moreover, the fraction of the folded 
material could be quantitatively extracted by the mild detergent DDM (Suppl. Fig. 4, 
Suppl. Table 3).  
Translation of the first ORF is not required for improved expression 
To determine whether translation of the first ORF was required for the beneficial effects 
of transcriptional fusions, we disrupted the start codons in mstX and ybeL. Disruption 
was done by the insertion of a single base in the respective start codons making 
translation highly unlikely. No major changes in the expression levels of the target 
proteins were observed upon abolishment of the MstX and YbeL expression, except for 
an increased production of misfolded Y4 GPCR upon removal of the MstX start codons 
(Fig. 3). These experiments suggest that the increased expression of the respective 
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membrane proteins cannot be attributed to re-initiation of ribosomes, which arrive at the 
3’  end  of  the  mstX and ybeL genes on the expression constructs. Instead, the cause for 
the enhanced expression levels of transcriptional fusions must be due to more favorable 
folding of the messenger RNA. 
3’  fragments  of  mstX and ybeL do not suffice for improved expression 
We subsequently probed the region of the fusion partner most relevant for the observed 
effects  by  making  truncations  from  the  5’  side  of  mstX'(ATG1/79) and ybeL'(ATG1) and 
assessing its effect on expression of AraH and NarK. The truncated constructs 
contained the last 180, 90 and 30 nucleotides of mstX and ybeL corresponding to 
approximately 50, 25 and 8% of the respective genes (Fig. 4A). A progressive 
shortening of mstX from   the   5’   side   resulted   in   decreased   expression   levels   of   the  
fluorescent species for both AraH and NarK (Fig. 4B). Moreover, these decreased 
functional expression levels were accompanied by increased levels of misfolded protein 
for the -180 and -90 constructs. The shortest construct, -30, did not show any misfolded 
protein. Similar observations were made for expression of AraH using a transcriptional 
fusion  to  5’  truncations  of  ybeL, though here no misfolded protein was detected at all.  
The decreased expression levels of the fluorescent species upon truncating the fusion 
partners   from   the   5’   side   indicate   that   the   beneficial   effects   of   these   transcriptional  
fusions cannot be explained by more favorable secondary structures in the mRNA 
involving exclusively nucleotide fragments nearby the SD preceding araH or narK. 
Rather,   this  suggests  an   important   role  of  nucleotides   in   the  5’  half  of  mstX and ybeL 
and potentially a long-range interaction in the mRNA, in establishing conditions for 
improved protein expression. 
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Large scale expression and purification of the ABC transporter EF583/584 from E. 
faecalis 
As EF583/584 expressed to one of the lowest levels of the four test targets, we further 
investigated on this protein to determine the practical use of the transcriptional fusion 
approach. Cells expressing EF583/584 as such (“direct  expression”)  or as transcriptional 
fusions to mstX or ybeL, were grown in identical preparative volumes and the transporter 
was purified by IMAC. Analyses of the eluted fractions by SDS-PAGE (Fig. 5A) are in 
good agreement with the expected yields based on in gel GFP fluorescence (Fig. 3). 
Direct expression resulted in barely detectable bands of the dimer, confirming our 
previous observation that expression yields were insufficient to obtain pure protein in a 
single IMAC purification step [44]. In contrast, yields were improved using transcriptional 
coupling to mstX and best, in term of purity and quantity, using transcriptional coupling 
to ybeL. Although only the EF584 subunit was tagged with a C-terminal GFP-His10, the 
untagged EF583 chain was co-purified in stoichiometric amounts (Fig. 5A and B). SEC 
analysis of IMAC-purified EF583/584 revealed a main peak at a retention volume of 12 
ml with a A254/A280 ratio of 0.55 and a peak width of around 3.5 ml, indicative of a pure 
and monodisperse protein sample (Fig. 5C, Suppl. Fig. 5). The protein yield of this main 
peak amounts to 0.1 mg of pure and monodisperse EF583/584 per liter of culture. This 
suffices to perform crystallization experiments. Moreover, using richer and buffered 
media such as TB [46] this value is expected to increase further. The minor peak at 9 ml 
retention volume exhibited an A254/A280 ratio of around 1.3 indicating that it consists 
mostly of co-purified DNA (Suppl. Fig. 5). The elution profile of EF583/584 is very similar 
to the profile obtained for TM287/288, a heterodimeric ABC transporter from 
Thermotoga maritima for which we obtained well-diffracting crystals [44] (Suppl. Fig. 5). 
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Due to the additional presence of a C-terminal GFP on EF584, EF583/584 elutes slightly 
earlier than TM287/288.  
The stoichiometric co-purification of the untagged subunit of the heterodimeric ABC 
transporter EF583/584 as well as a SEC profile similar to a related and crystallized 
heterodimeric ABC transporter are strong indications that EF583/584 was expressed in 
a properly folded state. Taken together, these results demonstrate that transcriptional 
coupling can improve the expression of a membrane protein to such a degree that it 
becomes amenable to protein purification at decent yields and purity, which is a 
prerequisite for structural and functional characterization.  
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Discussion 
The use of N-terminal translational fusion proteins is a well-established method to 
circumvent low expression levels for both soluble and membrane proteins. In part, the 
beneficial effects of these fusion proteins can be explained by improved characteristics 
of the resulting fusion protein compared to the unfused protein. Examples are an 
increased solubility using N-terminal MBP [9, 10], a correct topology of membrane 
proteins using signal peptides [47], or a decreased susceptibility towards proteases [48]. 
Next to this, fusions can also be effective at the pre-translation phase, e.g., by 
decreasing the stability of secondary structure elements in the mRNA and improving 
translation initiation [15]. Here we explored the use of fusions at the mRNA level to 
enhance expression of membrane proteins. 
The importance of favourable mRNA secondary structure at the initiation region has 
been illustrated by several studies. Kudla et al. [15] concluded that decreased stability of 
the secondary structure around the start site correlated best with the increased 
expression levels in their GFP library. Furthermore, small modifications in the  5’  region  
of the ORF have been shown to improve expression both in vivo [42, 49] and in vitro 
[16]. In addition, it was observed that modification of the sequence near the SD [50] or 
preceding the start codon [51, 52] affect expression levels. Finally, a genome-wide 
analysis on ~400 bacterial genomes demonstrated that evolution has selected 
sequences at the initiation region that weaken mRNA secondary structure, thus 
facilitating translation initiation [53].  
We have created bicistronic mRNA cassettes where the stop codon of the preceding 
gene (mstX, sumo, or ybeL) overlaps with the start codon of the protein of interest, 
AC
CE
PT
ED
 M
AN
US
CR
IPT
ACCEPTED MANUSCRIPT
 
17 
 
thereby mimicking a common genetic organization observed for bacterial operons 
[22,27] . As opposed to translational fusions, transcriptional fusions offer the advantage 
that the ribosome produces two distinct protein products during translation, thereby 
eliminating the need to enzymatically remove the fusion protein during purification. 
Moreover, this approach eliminates potential interference of the fusion partner in proper 
folding and functioning of the target protein [17, 19]. To the best of our knowledge, this is 
the first report on using transcriptional coupling for achieving overexpression of 
membrane proteins.  
Compared to translational fusions, the quality and quantity of the well-characterized 
target membrane proteins ProW, MscL, LacY and GltP was improved using 
transcriptional fusions to mstX and ybeL. The negative results obtained with sumo were 
expected to result from the absence of a SD at its  3’  end. However, insertion of a strong 
SD sequence into sumo at an optimal distance from the start codon of the downstream 
ORF only slightly increased expression levels. As translational fusions to SUMO often 
lead to overexpression of target proteins, we hypothesize that here the mRNA 
secondary structure at   the   3’   end   of sumo decreases the accessibility of the SD 
sequence thereby reducing translation initiation of the target proteins.   
The modest improvement in expression of well-folded material for the initial target 
proteins ProW, MscL, LacY and GltP compared to direct expression of these proteins, 
suggests that for these proteins the translation initiation is not limiting their expression. 
Rather their downstream processing (e.g., membrane targeting, insertion and folding) 
represents the bottleneck, as evident from the large amounts of misfolded material. To 
test the use of transcriptional fusions we thus subsequently used more challenging 
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targets, selected based on published negative results [42, 44, 45]. We could confirm low 
expression levels for AraH, EF583/584 and Y4 GPCR. Importantly, for these proteins 
transcriptional fusions to mstX or ybeL did lead to a significant increase in the amount of 
well-folded material. As a final demonstration of the beneficial effects of transcriptional 
fusions to overexpression of a membrane protein, we produced the heterodimeric ABC 
transporter EF583/584 using direct expression or transcriptional fusion to either mstX or 
ybeL, and purified the resulting protein. Clearly, more well-folded material was obtained 
using transcriptional fusion to ybeL allowing to acquire sufficient quantities for structural 
and functional studies.  
We speculate that increased expression of membrane proteins achieved by 
transcriptional coupling can be explained by the fact that the translation initiation region 
in some genes coding for membrane proteins are occluded by secondary mRNA 
structures, and that the presence of an upstream gene such as mstX or ybel would 
render that region more accessible to ribosomes. Importantly, the observed decreased 
expression levels of the fluorescent species upon truncating the fusion partners from 
their 5’   side   suggest   that   long-range mRNA interactions are particularly relevant here 
(Fig. 4B). Although occluded initiation regions will not be the only reason why membrane 
proteins are difficult to express, an improved understanding of the role of secondary 
structures in the 5’-UTR could lead to the design of better expressing constructs.  
While comparing the different transcriptional fusion partners, we made the interesting 
observation that the use of ybeL significantly reduced the fraction of misfolded 
membrane proteins, while the amount of folded material remained high (Fig. 2 and 3). 
We could exclude that this resulted from a decreased protein production rate that did not 
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exceed the capacity of the downstream targeting, insertion and folding machinery: the 
expression levels of well-folded target protein using ybeL are not lower, but similar to 
transcriptional fusion to mstX; furthermore, decreased production rates would result in 
maximal expression levels at a higher inducer concentration. Such a shift was not 
observed, instead, all constructs had a very similar optimal inducer concentration (Suppl. 
Fig. 2). Next to this, as YbeL is a soluble protein [14] it is also unlikely that it facilitates 
the migration of the polyribosome-mRNA to the membrane, thereby overcoming the 
potentially limiting step of targeting the ribosome-nascent chain complex to the 
membrane. In addition, translation of YbeL is not required for this effect (Fig. 3). 
Whereas it is clear that membrane protein insertion and folding is a co-translational 
process, the influence of the transcript on this process is poorly understood.  
Taken together, we have shown that transcriptional fusions to mstX, but most 
successfully using ybeL, can enhance the expression of membrane proteins. The cause 
of this effect is most likely the enhanced translation initiation by more favourable 
secondary structure in the transcript. Transcriptional fusions enhancing expression can 
avoid the use of translational fusions. Thereby problems associated with cleavage of the 
folding partner and interference with proper folding and functioning can be avoided. 
Though fusion of the target protein to the N-terminus of GFP facilitates the interpretation 
of expression trials, this is not absolutely required for this approach, and target proteins 
can be produced with minimal tags if needed. We anticipate that transcriptional fusions 
may also be advantageous for the production of soluble proteins. 
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Materials and methods 
Vector construction 
To enable the insertion of various sequences preceding the target ORFs, vector 
pBXC3GH [37] was modified to contain a unique XhoI site between the start codon and 
the serine codon that immediately preceded the target ORF. The XhoI site was 
introduced by PCR using phosphorylated primers. Following PCR and DpnI treatment, 
the PCR product was column-purified, ligated using T4 DNA ligase and transformed to 
E. coli DB3.1 cells. Relevant regions were verified by sequencing. The final vector was 
designated pBX-XhoI-C3GH. 
Genes coding for Mistic (mstX), SUMO (sumo) and a shorter version of YbeL (ybeL 1-
360 bp) were PCR-amplified  using  primers  containing  XhoI  sites  at  their  5’  termini  using  
pBXNHmistic, pBXNHsumo and pBXNHybel as template, respectively. Gel-purified PCR 
products were digested with XhoI, re-purified and ligated into XhoI-digested, 
dephosphorylated and gel-purified pBX-XhoI-C3GH. Correct orientation of the inserts 
was verified by sequencing. The final vectors for expression of target ORFs as fusion 
proteins to Mistic, SUMO, or YbeL were designated pBXMstXC3GH, pSUMOC3GH and 
pYbeLC3GH, respectively. 
Vectors for transcriptional fusions were constructed similarly as described for 
translational fusions, except that during PCR a TGA stop codon was introduced to mstX, 
sumo and ybeL. Furthermore, the penultimate codon of ybeL was changed from GTC to 
GTA. Thus, the last four bases of every sequence read ATGA and comprised the TGA 
stop codon of the upstream ORF and the ATG start codon of the downstream ORF. 
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Vectors were verified by sequencing and designated pBXMstXTGAC3GH, 
pBXSUMOTGA3CGH and pBXYbeLTGA3CGH. 
Ribosome binding sites in mstX, sumo and ybeL in pBXMstXTGAC3GH, 
pBXSUMOTGA3CGH and pBXYbeLTGA3CGH were removed (mstX and ybeL) or 
introduced (sumo)  by  PCR.  Sequence  and  strength  of  the  RBS’s  were  estimated  using  
RBS Designer [40].  RBS’s  in  mstX and ybeL were replaced by a polyadenine sequence 
predicted to not serve as a RBS. Vectors were verified by sequencing and designated 
pBXMstXTGAC3GHΔSD,  pBXSUMOTGAC3GH+SD  and  pBXybeLTGAC3GHΔSD. 
Translation of mstX and ybeL was avoided by creating a frame shift in relevant start 
codons (ATG to ATaG). Next to the ATG at position 1, for mstX this involved the 
alternative start codon at position 79 as well. The additional nucleotide was introduced 
by PCR using pBXMstXTGAC3GH and pBXYbeLTGAC3GH as templates, yielding 
vectors  pBXMstXTGAC3GHΔATG1 and  pBXYbeLTGAC3GHΔATG1. For introduction of 
the additional nucleotide at position 79 in mstX,  plasmid  pBXMstXTGAC3GHΔATG1 was 
used  as  template  resulting  in  pBXMstXTGAC3GHΔATG1-79. 
Genes coding for proW, mscL, gltP, araH, and narK were amplified from genomic DNA 
of E. coli MC1061,  lacY was amplified from pBADcLIC-GFP(lacY) [6], ABC V583 was 
amplified from genomic DNA of E. faecalis V583, and the sequence coding for the 
human Y4 GPCR was amplified from a plasmid obtained as previously described [45]. 
Gel-purified PCR products were cloned into pINITIAL using FX cloning as described 
[37]. The sequence-verified ORFs were subsequently used for subcloning into the 
expression vectors detailed above. 
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 pBXMstXTGAC3GHΔATG1-79 and  pBXYbeLTGAC3GHΔATG1 were used as templates 
to produce FX compatible plasmids where mstX and ybeL were reduced at sequences 
corresponding to their last 30, 90 or 180 nucleotides, starting from the codons 
corresponding to amino acids S102, Y82, I52 (MstX) and G112, D92, F62 (YbeL), 
respectively. Plasmids were amplified using phosphorylated primers in order to include 
the SD1 present on the vector, using the same purification strategy described above. 
Whole cell fluorescence determination 
Single colonies of E. coli MC1061 transformed with relevant expression vectors were 
used  to  start  overnight  cultures  in  700  μl  of  LB  supplemented  with  100  μg/ml  ampicillin  in  
a 96 deep-well plate. Cells were grown overnight at 37°C under vigorous shaking. A 1% 
inoculum  was  used   to  start  cultivation   in  700  μl  LB-Amp and cells were grown for two 
hours at 37°C after which the temperature of the shaker was set to 25°C. One hour later, 
expression was induced by the addition of 0.2 % (w/v) L-arabinose. Cells expressing 
ProW, MscL, LacY, and GltP were harvested after 5 hours, while expression of AraH, 
NarK, ABCV583 and Y4 GPCR was carried out overnight. Cells were harvested by 
centrifugation (3000 x g for  10  min)  at  4°C,  washed  with  500  μl  ice-cold PBS buffer and 
finally  resuspended  in  300  μl.  A  volume  of  150  μl was used to determine whole cell GFP 
fluorescence in a black 96 well plate; the OD600 was   determined   using   50   μl   in   a  
transparent 96-well plate. Fluorescence measurements were carried out in an Infinite 
M1000 plate reader (Tecan, Switzerland) with excitation at 485 nm and emission at 535 
nm. Fluorescence values were normalized by optical densities, and mean values were 
obtained by performing experiments in triplicates. Experiments were performed three 
times independently at a minimum.  
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Dual electrophoretic mobility analysis 
In gel fluorescence and western blotting analysis were performed as described 
previously [6], with the exception that identical amounts of cells corresponding to ~ 2 mg 
of total cellular protein were used that were derived from a pooled sample of three 
independent   cultures.  Furthermore,   cell   pellets  were   resuspended   in  350  μl  of  50  mM  
KPi buffer pH 7.5, supplemented with protease inhibitors tablets (Complete mini, 
Roche),  10%  glycerol,  lysozyme  (1  mg/ml),  and  DNase  (20  μg/ml).   
Solubilization in DDM and FSEC analysis 
Small scale solubilization tests on AraH, NarK, EF583/584 and Y4 GPCR (Suppl. Fig. 4, 
Suppl. Table 3) were carried out as described before [6]. Samples corresponding to the 
solubilized fraction after ultracentrifugation were subsequently used to perform FSEC 
analysis. Undiluted and diluted (1:10) samples were placed in a 96 well plate. Dilution 
was done to avoid saturation of the fluorescence detector for well expressing proteins. 
Samples were run on an analytical size exclusion column (Superdex 200 5/150 GL, GE) 
at 4°C in 50 mM Tris.HCl, pH 7.5, 150 mM NaCl, and 2 mM DDM, using an Agilent 
Technologies 1100 Series HPLC coupled to an Agilent 1260 Infinity fluorescence 
detector. 
Large scale expression and purification of the ABC transporter EF583/584 
The ABC transporter EF583/584 from E. faecalis was expressed in E. coli MC1061 
without any N-terminal fusion using the pBXC3GH vector, or via transcriptional fusion to 
mstX or ybeL (pBXMstXTGAC3GH and pBXybeLTGAC3GH). Single colonies were used 
to inoculate 10 ml of LB-AMP medium and grown overnight at 37°C. The precultures 
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were diluted 1:100 in 600 ml of LB-AMP per culture flask and three flasks were used for 
each of the three constructs. Expression of EF583/584 cloned into pBXybeLC3GH was 
further scaled up to 6 l of LB-AMP. Cultivation was performed as described for whole cell 
fluorescence determination and induction was done overnight. Membrane vesicle 
preparation and IMAC were carried out exactly as described previously [44, 45], using 1 
% of n-dodecyl-β-D-maltoside (DDM) for solubilization. Size exclusion chromatography 
was carried out using a Superdex 200 10/300 GL column (GE Healthcare).   
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Figure legends 
Fig. 1. Schematic representation of the three different approaches used to express 
ProW, MscL, LacY and GltP. Sequences coding for fusion partners, membrane 
proteins and GFP are indicated by fp, MP-ORF, and gfp, respectively. The topology of 
the resulting protein(s) is indicated on the right. The location of the SD sequences in the 
fusion partners and the translation efficiency (defined as the probability of a given mRNA 
being bound to a ribosome) were predicted using the RBS-designer software [40, 54]. 
SD sequences and the overlapping Start/Stop codon are indicated in bold. The 
translation efficiency of the (first) SD sequence encoded by the pBAD vector was 
predicted to be 3.0*10-1.  
Fig. 2 Differential electrophoretic mobility analysis of ProW, MscL, LacY and GltP 
expressed with a C-terminal GFP. Proteins were expressed directly, as translational 
fusions with N-terminal Mistic, SUMO or YbeL, or via transcriptional fusions with mstX, 
sumo and ybeL. In the left panels the protein is detected by in gel GFP fluorescence, in 
the right panels immunoblots of the same gels are shown where the protein is detected 
using an anti-His antibody. The lower, fluorescent band, indicative of well-folded protein, 
and the upper non-fluorescent band, indicative of misfolded material, are indicated by 
white and black arrows, respectively. Identical amounts of cells were used for each 
sample. 
Fig. 3. Differential electrophoretic mobility analysis of AraH, NarK, EF583/584 and 
Y4 GPCR expressed with a C-terminal GFP. Proteins were expressed directly or as 
transcriptional fusions to mstX or ybeL. The two most right lanes of each panel represent 
expression using transcriptional fusions for which the fusion partner is not expressed 
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due to disruption of (potential) start codons. In the left panels the protein is detected by 
in gel GFP fluorescence, in the right panels immunoblots of the same gel are shown 
where the protein is detected using an anti-His antibody. The lower, fluorescent band, 
indicative of well-folded protein, and the upper non-fluorescent band, indicative of 
misfolded material, are indicated by white and black arrows, respectively. Identical 
amounts of cells were used for each sample. 
Fig. 4. Differential electrophoretic mobility analysis of AraH and NarK 
transcriptionally fused to a 5’ truncated mstX or ybeL derivative. A) Schematic 
representation of the nucleotide starting positions of mstX'(ATG1/79) and ybeL'(ATG1) 
5’  truncations. Sequences coding for fusion partners, membrane proteins and GFP are 
indicated by fp, MP-ORF, and gfp, respectively. B) Proteins with a C-terminal GFP were 
expressed directly or as transcriptional fusions to mstX or ybeL derivatives. In the left 
panels the protein is detected by in gel GFP fluorescence, in the right panels 
immunoblots of the same gel are shown where the protein is detected using an anti-His 
antibody. The lower, fluorescent band, indicative of well-folded protein, and the upper 
non-fluorescent band, indicative of misfolded material, are indicated by white and black 
arrows, respectively. Identical amounts of cells were used for each sample. 
Fig. 5. Purification of the ABC transporter EF583/584. A) Expression was performed 
directly or via transcriptional coupling to mstX or ybeL. Proteins were purified under 
identical conditions using IMAC and three consecutive elution fractions were analyzed 
by SDS-PAGE and stained with Coomassie. Expression using transcriptional coupling to 
ybeL was further scaled-up and analyzed by SEC. B) Peak fractions were analyzed by 
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SDS-PAGE and stained with Coomassie. C) Analysis of the IMAC-purified protein by 
SEC using a Superdex 200 10/300 GL column. 
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Figure 5  
